Research shows that certain gut bacteria enhance GLP-1 production through fermentation of soluble fiber into short-chain fatty acids
Selected recent literature for research reference: Coutinho LFD et al
There is really no feasible way to reduce the side effects of intravenous administration
For example, those on the lowest dose lost about 8.7% of their weight, while those on the highest dose lost 24.2%
If a consumer is eating less, the eating experience needs to be worth it. A reduced appetite may make it challenging to maintain adequate nutrient intake while taking GLP-1 medication, so food formulators have an opportunity to close the gap
Clifton Jackness, MD Clifton Jackness, MD, is an attending physician in endocrinology, diabetes, and metabolism at Lenox Hill Hospital and The Mount Sinai Medical Center in New York City.